Literature DB >> 20879894

Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus.

Erhard van der Vries, Foekje F Stelma, Charles A B Boucher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20879894     DOI： 10.1056/NEJMc1003749

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  87 in total

1.  Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferrets.

Authors:  Elena A Govorkova; Bindumadhav M Marathe; Ashley Prevost; Jerold E Rehg; Robert G Webster
Journal:  Antiviral Res       Date:  2011-05-27       Impact factor: 5.970

2.  Comparison of ribavirin and oseltamivir in reducing mortality and lung injury in mice infected with mouse adapted A/California/04/2009 (H1N1).

Authors:  Sotirios G Zarogiannis; James W Noah; Asta Jurkuvenaite; Chad Steele; Sadis Matalon; Diana L Noah
Journal:  Life Sci       Date:  2012-01-16       Impact factor: 5.037

3.  Emerging influenza antiviral resistance threats.

Authors:  Frederick G Hayden; Menno D de Jong
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

4.  Recovery of influenza B virus with the H273Y point mutation in the neuraminidase active site from a human patient.

Authors:  Rachel R Higgins; Melissa Beniprashad; Eddie Chong-King; Yan Li; Nathalie Bastien; Donald E Low; Jonathan B Gubbay
Journal:  J Clin Microbiol       Date:  2012-04-25       Impact factor: 5.948

Review 5.  Pandemic influenza: a never-ending story.

Authors:  Seiji Kageyama
Journal:  Yonago Acta Med       Date:  2011-09-01       Impact factor: 1.641

6.  Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis.

Authors:  Evelien Vanderlinden; Bram Vrancken; Jeroen Van Houdt; Vivek K Rajwanshi; Sarah Gillemot; Graciela Andrei; Philippe Lemey; Lieve Naesens
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

Review 7.  Influenza prevention and treatment in transplant recipients and immunocompromised hosts.

Authors:  Michael G Ison
Journal:  Influenza Other Respir Viruses       Date:  2013-11       Impact factor: 4.380

Review 8.  Detection and management of antiviral resistance for influenza viruses.

Authors:  Guy Boivin
Journal:  Influenza Other Respir Viruses       Date:  2013-11       Impact factor: 4.380

9.  Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring.

Authors:  Elena A Govorkova; Tatiana Baranovich; Patrick Seiler; Jianling Armstrong; Andrew Burnham; Yi Guan; Malik Peiris; Richard J Webby; Robert G Webster
Journal:  Antiviral Res       Date:  2013-02-28       Impact factor: 5.970

10.  Identification of a broad-spectrum inhibitor of viral RNA synthesis: validation of a prototype virus-based approach.

Authors:  Claire Marie Filone; Erin N Hodges; Brian Honeyman; G Guy Bushkin; Karla Boyd; Andrew Platt; Feng Ni; Kyle Strom; Lisa Hensley; John K Snyder; John H Connor
Journal:  Chem Biol       Date:  2013-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.